Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination drug containing two active ingredients: **glycerol** (also known as glycerin) and **paracetamol** (also known as acetaminophen). Glycerol is an osmotic laxative and humectant used to relieve constipation by drawing water into the intestines, softening stools, and facilitating bowel movements. Paracetamol is an analgesic and antipyretic agent widely used for the relief of mild to moderate pain and fever. The mechanism of action for paracetamol involves inhibition of prostaglandin synthesis in the central nervous system (CNS), leading to reduced pain perception and fever; its exact mechanism remains not fully elucidated but includes central effects on the hypothalamus for antipyresis. Combination products may be formulated for specific indications such as symptomatic relief where both stool softening/laxative effect and analgesia/antipyresis are desired[6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycerol + paracetamol.